Rifaximin Clinical Trials
5 recruitingDrug
Not Applicable2Phase 22Phase 32
Showing 1–5 of 5 trials
Recruiting
Phase 2
Rifaximin Versus No Intervention for the Treatment of IgA Monoclonal Gammopathy of Undetermined Significance
IgA Monoclonal Gammopathy of Undetermined Significance
Fred Hutchinson Cancer Center50 enrolled1 locationNCT07209371
Recruiting
Not Applicable
Human Albumin Infusion in Liver Cirrhosis and Overt Hepatic Encephalopathy (HACHE)
Overt Hepatic Encephalopathy
General Hospital of Shenyang Military Region174 enrolled1 locationNCT06483737
Recruiting
Phase 2Phase 3
Effects of Rifaximin on Gut Microbiota and Emotion
StressHealthy VolunteersFear
Universitaire Ziekenhuizen KU Leuven60 enrolled1 locationNCT05587036
Recruiting
Not Applicable
Rifaximin and Cardiac Function in Patients with Heart Failure with Preserved Ejection Fraction
Bacterial Overgrowth Syndrome Small Bowel
I.M. Sechenov First Moscow State Medical University40 enrolled1 locationNCT06652087
Recruiting
Phase 3
Efficacy and Safety of Nitazoxanide in Preventing Recurrence of Hepatic Encephalopathy
Hepatic Encephalopathy
Tanta University60 enrolled1 locationNCT04161053